Google: Interstitials are Fine Under this Condition


Google: Interstitials are Fine Under this Condition

Google's John Mueller offered a nuanced explanation of how the negative ranking factor related to interstitials works

How to Run Experiments with Web Interstitials in Google Ad Manager

Want help with your Interstitials? Let’s talk! &utm_medium=social &utm_campaign=allyseo

Subscribe to keep up with the AdTech Industry Buzz & make more money from your blog or app.


Interstitial Lung Disease (ILD) Research Part 2

Interstitial Lung Disease (ILD) Research Part 2

Speaker: Theresa Altherr, BA, CIP, CCRP

Video recorded at the May 13, 2019 meeting of Breathmatters.

Theresa Altherr provided an overview of clinical research, why it is important and what it can provide to participants. With research conducted through the testing and the standard four phases of study, improved treatments are developed which can save lives and improve conditions for lung disease sufferers.

She discussed what kind of person is best suited to become involved in clinical research, and how the doctors of the research team will first confirm the patient original diagnoses before placing them within the study.

Also described is the burgeoning importance of genetic research which helps to identify the best candidates for the receiving of experimental drugs.

Video recorded at the monthly Breathmatters meeting held May 13, 2019 at Johnston-Willis Hospital in Midlothian Virginia in Stalker Auditorium.

BREATHMATTERS is a 501 (c)3 non-profit Richmond Virginia support group dedicated to helping people with lung disease

Information Central Virginia 804-937-6855

Camera and edit by Erik Weems.

An introduction to Connective Tissue Disease-associated Interstitial Lung Disease (CTD-ILD) webinar

Presented by Respiratory and Sleep Physician, Dr Adelle Jee, and consumer representative, Tania, this video provides an overview of Connective Tissues Disease-associated Interstitial Lung Disease (CTD-ILD) and gives an insight into how to navigate the diagnosis and management journey to get the most out of your treatment and care.

Could zinc be the key to stopping this deadly lung disease?

More than 100,000 seniors suffer from idiopathic pulmonary fibrosis (IBF). There’s no cure, but doctors are now one step closer to stopping its progression.

Read more:

Subscribe to WQAD News 8 on YouTube:
Other ways to watch News 8:
Download the News 8 app on IOS:
Download the News 8 app on Android: &hl=en_US &gl=US

‘Like’ WQAD on Facebook:
Follow WQAD on Twitter:
Follow WQAD on Instagram:

You Might Also Like